Annual EBITDA
-$213.40 M
-$92.83 M-76.99%
December 31, 2023
Summary
- As of February 7, 2025, BNGO annual EBITDA is -$213.40 million, with the most recent change of -$92.83 million (-76.99%) on December 31, 2023.
- During the last 3 years, BNGO annual EBITDA has fallen by -$176.32 million (-475.53%).
- BNGO annual EBITDA is now -1252.40% below its all-time high of -$15.78 million, reached on December 31, 2018.
Performance
BNGO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$38.47 M
-$25.71 M-201.43%
September 1, 2024
Summary
- As of February 7, 2025, BNGO quarterly EBITDA is -$38.47 million, with the most recent change of -$25.71 million (-201.43%) on September 1, 2024.
- Over the past year, BNGO quarterly EBITDA has dropped by -$3.09 million (-8.74%).
- BNGO quarterly EBITDA is now -1432.10% below its all-time high of -$2.51 million, reached on June 30, 2018.
Performance
BNGO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$114.88 M
+$70.31 M+37.97%
September 1, 2024
Summary
- As of February 7, 2025, BNGO TTM EBITDA is -$114.88 million, with the most recent change of +$70.31 million (+37.97%) on September 1, 2024.
- Over the past year, BNGO TTM EBITDA has increased by +$98.95 million (+46.28%).
- BNGO TTM EBITDA is now -2119.05% below its all-time high of -$5.18 million, reached on March 31, 2017.
Performance
BNGO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BNGO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -77.0% | -8.7% | +46.3% |
| 3 y3 years | -475.5% | -39.3% | -24.1% |
| 5 y5 years | -1252.4% | -433.4% | -294.7% |
BNGO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -188.9% | at low | -201.4% | +64.6% | -55.5% | +46.3% |
| 5 y | 5-year | -709.0% | at low | -457.0% | +64.6% | -333.6% | +46.3% |
| alltime | all time | -1252.4% | at low | -1432.1% | +64.6% | -2119.1% | +46.3% |
Bionano Genomics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$38.47 M(+201.4%) | -$114.88 M(-38.0%) |
| Jun 2024 | - | -$12.76 M(-54.8%) | -$185.19 M(-11.1%) |
| Mar 2024 | - | -$28.26 M(-20.1%) | -$208.31 M(-2.6%) |
| Dec 2023 | -$213.40 M(+77.0%) | -$35.38 M(-67.5%) | -$213.83 M(+0.7%) |
| Sep 2023 | - | -$108.78 M(+203.1%) | -$212.43 M(+59.8%) |
| Jun 2023 | - | -$35.89 M(+6.2%) | -$132.93 M(+4.9%) |
| Mar 2023 | - | -$33.78 M(-0.6%) | -$126.73 M(+5.1%) |
| Dec 2022 | -$120.57 M(+63.3%) | -$33.98 M(+16.1%) | -$120.57 M(+6.3%) |
| Sep 2022 | - | -$29.28 M(-1.4%) | -$113.38 M(+8.7%) |
| Jun 2022 | - | -$29.69 M(+7.5%) | -$104.29 M(+12.6%) |
| Mar 2022 | - | -$27.63 M(+3.2%) | -$92.59 M(+25.4%) |
| Dec 2021 | -$73.86 M(+99.2%) | -$26.78 M(+32.6%) | -$73.86 M(+28.1%) |
| Sep 2021 | - | -$20.19 M(+12.2%) | -$57.64 M(+21.7%) |
| Jun 2021 | - | -$17.99 M(+102.4%) | -$47.35 M(+29.5%) |
| Mar 2021 | - | -$8.89 M(-15.8%) | -$36.58 M(-1.5%) |
| Dec 2020 | -$37.08 M | -$10.56 M(+6.6%) | -$37.13 M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$9.91 M(+37.4%) | -$33.48 M(+15.0%) |
| Jun 2020 | - | -$7.21 M(-23.7%) | -$29.11 M(+1.6%) |
| Mar 2020 | - | -$9.45 M(+36.8%) | -$28.64 M(+8.1%) |
| Dec 2019 | -$26.38 M(+67.2%) | -$6.91 M(+24.7%) | -$26.50 M(+3.6%) |
| Sep 2019 | - | -$5.54 M(-17.9%) | -$25.57 M(+5.8%) |
| Jun 2019 | - | -$6.75 M(-7.6%) | -$24.17 M(+21.3%) |
| Mar 2019 | - | -$7.30 M(+22.0%) | -$19.93 M(+26.3%) |
| Dec 2018 | -$15.78 M(-25.8%) | -$5.98 M(+44.8%) | -$15.78 M(+5.1%) |
| Sep 2018 | - | -$4.13 M(+64.6%) | -$15.02 M(-3.7%) |
| Jun 2018 | - | -$2.51 M(-20.3%) | -$15.59 M(-18.9%) |
| Mar 2018 | - | -$3.15 M(-39.7%) | -$19.23 M(-9.5%) |
| Dec 2017 | -$21.25 M(+23.2%) | -$5.22 M(+11.0%) | -$21.25 M(+32.6%) |
| Sep 2017 | - | -$4.70 M(-23.5%) | -$16.03 M(+41.5%) |
| Jun 2017 | - | -$6.15 M(+18.8%) | -$11.33 M(+118.8%) |
| Mar 2017 | - | -$5.18 M | -$5.18 M |
| Dec 2016 | -$17.25 M | - | - |
FAQ
- What is Bionano Genomics annual EBITDA?
- What is the all time high annual EBITDA for Bionano Genomics?
- What is Bionano Genomics annual EBITDA year-on-year change?
- What is Bionano Genomics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bionano Genomics?
- What is Bionano Genomics quarterly EBITDA year-on-year change?
- What is Bionano Genomics TTM EBITDA?
- What is the all time high TTM EBITDA for Bionano Genomics?
- What is Bionano Genomics TTM EBITDA year-on-year change?
What is Bionano Genomics annual EBITDA?
The current annual EBITDA of BNGO is -$213.40 M
What is the all time high annual EBITDA for Bionano Genomics?
Bionano Genomics all-time high annual EBITDA is -$15.78 M
What is Bionano Genomics annual EBITDA year-on-year change?
Over the past year, BNGO annual EBITDA has changed by -$92.83 M (-76.99%)
What is Bionano Genomics quarterly EBITDA?
The current quarterly EBITDA of BNGO is -$38.47 M
What is the all time high quarterly EBITDA for Bionano Genomics?
Bionano Genomics all-time high quarterly EBITDA is -$2.51 M
What is Bionano Genomics quarterly EBITDA year-on-year change?
Over the past year, BNGO quarterly EBITDA has changed by -$3.09 M (-8.74%)
What is Bionano Genomics TTM EBITDA?
The current TTM EBITDA of BNGO is -$114.88 M
What is the all time high TTM EBITDA for Bionano Genomics?
Bionano Genomics all-time high TTM EBITDA is -$5.18 M
What is Bionano Genomics TTM EBITDA year-on-year change?
Over the past year, BNGO TTM EBITDA has changed by +$98.95 M (+46.28%)